ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Up ? in July

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 107,454 shares, a growth of ? from the June 30th total of 0 shares. Based on an average daily volume of 210,818 shares, the short-interest ratio is currently 0.5 days.

ProtoKinetix Stock Performance

Shares of OTCMKTS:PKTX remained flat at $0.00 during trading on Wednesday. 2,464 shares of the stock were exchanged, compared to its average volume of 152,084. The firm has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.01. ProtoKinetix has a 52 week low of $0.00 and a 52 week high of $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.